Programme leads


Professor Paul MatthewsProfessor Paul Matthews

Exploring glial-neuronal interactions at the transition from brain vulnerability to pathology

Paul M. Matthews, OBE, DPhil, FRCP, FMedSci is the Edmond and Lily Safra Professor of Translational Neuroscience and Therapeutics, Centre Director of the UK Dementia Research Institute Centre at Imperial, and Head of the Department of Brain Sciences, Imperial College London. Since 2009, he has been on the Steering Committee of UK Biobank and chairs the Imaging Enhancement Working Group, which has supported UK Biobank for creating the world’s largest population research imaging resource.

Previously, Matthews spent almost nine years as a Vice President in GlaxoSmithKline, holding a variety of senior portfolios, including those for the GSK Clinical Imaging Centre and the later Global Imaging Group. He jointly founded and was the first Director of Oxford FMRIB Centre (1995-2005). He is a Fellow by Special Election of St Edmund Hall, Oxford, a Fellow of the Academy of Medical Sciences, and a Fellow of the Academea Europea. He was awarded an OBE in 2008 for services to Neuroscience.

Paul was appoint Chair of the UK Medical Research Council (MRC) Neurosciences and Mental Health BoardHe is an NIHR Senior Investigator. His research addresses mechanisms of failure of glial-neuronal homeostatic mechanisms in the early stages of Alzheimer’s disease and in progressive multiple sclerosis. He always is pleased to hear from interested prospective students, scientists or others who share a common interest in helping science improve the lives of people with dementia and those of their families.

Line break

Wisden, WilliamProfessor William Wisden

The role of sleep in protecting against amyloid and glial pathology in dementia

Professor Wisden, MA, PhD, FMedSci, is Chair in Molecular Neuroscience in the Department of Life Sciences, Imperial College London. His interested in three major problems in neuroscience:

-- Why do we sleep and how is sleep initiated and maintained?

-- What are the molecular and neuronal mechanisms underlying the loss of consciousness induced by general anaesthetics? And,

-- What is the molecular basis of neuropathic pain?

He uses a wide variety of techniques and model systems to investigate these problems, including confocal microscopy, real-time PCR, proteomic analysis with mass spectrometry and structural biology.

Line break

Elliott, PaulProfessor Paul Elliott

Linking genetic, epidemiology and metabolic phenotyping in dementia in the context of ageing, environment and lifestyle

Professor Paul Elliott, MBBS, PhD, FMedSci, trained in clinical medicine and epidemiology as a Wellcome Trust Clinical Fellow at St Mary's Hospital London and the London School of Hygiene and Tropical Medicine. He studied for his PhD in Epidemiology on the INTERSALT Study under the mentorship of Professor Geoffrey Rose. He remained at the London School working as a lecturer, and subsequently as senior lecturer and reader in epidemiology before being appointed as Head of the Environmental Epidemiology Unit at LSHTM 1990. In 1995 he was appointed to the Chair in Epidemiology and Public Health Medicine at Imperial College London. 

Line break

Grossman, NirDr Nir Grossman

Developing novel bioelectronics technologies to modulate neurons and glia in the study of sleep, neuroprotection and cognition

Dr Grossman develops neuromodulatory interventions for brain disorders by pioneering new tools and principles to impact the disease pathology via direct modulation of the underlying aberrant neural activity.

His research drives innovation through rigorous scientific exploration of common biophysical principles and rules underpinning the neural processing of electromagnetic stimulation, using natural bridges between advanced computational neuroscience and cutting-edge experiments, ranging from a single neuron cell to human behaviour.

Line break

Samuel BarnesDr Samuel Barnes

Exploring the role of neural circuit plasticity in the susceptibility of the aged brain to neurodegeneration

Dr Barnes investigates why the aged brain is vulnerable to neurodegeneration in order to identify strategies that may alleviate this susceptibility.

His group focuses on homeostatic neural plasticity processes which are thought to be critical for healthy network function. The group uses a combination of voltage and calcium imaging, bioelectronics and electrophysiology to determine the efficiency and mechanisms of homeostatic plasticity processes in both the aged brain and the early stages of neurodegeneration.

Line break

Marco BrancaccioDr Marco Brancaccio

Exploring the role of circadian dysfunction in the early stages of dementia

Dr Brancaccio investigates the molecular, cellular and circuit mechanisms underlying circadian function in health and disease.

His group focuses on understanding the mechanisms driving circadian misregulation in the early stages of dementia. His laboratory uses a wide range of techniques including live imaging and in vivo gene therapy to study and harness circadian brain function with the aim of delaying disease onset and progression.

Line break

Yu YeDr Yu Ye

Protein homeostasis in cell stress

Dr Ye completed his PhD at MRC-LMB, and held a Junior Research Fellowship and a Sir Henry Wellcome Fellowship at University of Cambridge and Harvard Medical School. He is excited to return to his alma mater, where he will untangle the molecular agents causing dementia with the ubiquitin-proteasome system.

The Ye Lab studies the interplay between the ubiquitin-proteasome system and amyloid proteins in biological systems. Using advanced fluorescence imaging techniques, the lab seeks to uncover the cellular mechanisms of restricting or reversing protein aggregation, and how malfunction of this system leads to neurodegenerative disorders.

Line break

Nathan SkeneDr Nathan Skene

Neurogenomics

Nathan Skene completed his undergraduate degree in Artificial Intelligence and Cybernetics at the University of Reading, followed by an MPhil in Computational Biology at Cambridge. His PhD was at the Sanger Institute working with Prof Seth Grant on the Genes2Cognition programme. During his PhD he worked on analysing the transcriptomic changes seen in a mice carrying a wide range of synaptic mutations.

He did his postdoc in the lab of Jens Hjerling-Leffler at the Karolinska Institutet, where he developed a series of method which made it possible to identify cell types underlying complex diseases using GWAS data. Skene joined Imperial College London in 2019 as an Edmond and Lily Safra Research Fellow. His interests lie in using human genetics to gain insight into the neurobiology of brain disorders and cognitive traits.

Line break

Dr Sarah MarziDr Sarah Marzi

Neurogenomics

Dr Marzi uses genome-wide genetic and epigenetic techniques as well as innovative bioinformatic and statistical approaches to investigate epigenetic dysregulation in disease

 

Line break

 

Dr Alexi NottDr Alexi Nott

Neurogenomics

Epigenome of the brain: gene regulation in health and disease

Alexi completed his PhD at University College London investigating the function of epigenetic regulators during brain development. During his postdoctoral fellowship at MIT he investigated the role of epigenetics in postnatal development and autism-related behaviors. His research at the University of California, San Diego examined epigenetic mechanisms underlying age-related brain disorders and he identified microglia as associated with the genetic risk of Alzheimer’s disease.
His research utilizes nuclei isolation methods and genome-wide sequencing approaches to examine the epigenome of brain cell types using patient-derived archived tissue. Functional interrogation of disease-associated gene regulatory regions will employ CRIPSR DNA-editing technology of pluripotent stem cells derived into brain cell types. Using a combination of these approaches, Alexi will examine the epigenome of the human brain to understand how genetic variation contributes to age-related brain disorders.

Line break

Management team


Management team

Multi-'omics Atlas Project (MAP) team

Research staff


Research staff

PhD Students


PhD Students

Associates and collaborators 


Associates and collaborators